Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

CHARACTERIZATION OF THE SPONTANEOUS MURINE B CELL LEUKEMIA (BCL1) .3. EVIDENCE FOR MONOCLONALITY BY USING AN ANTI-IDIOTYPE ANTIBODY JOURNAL OF IMMUNOLOGY Vitetta, E. S., Yuan, D., Krolick, K., Isakson, P., Knapp, M., Slavin, S., Strober, S. 1979; 122 (5): 1649-1654

Abstract

We have raised an anti-idiotypic antibody against the cell surface IgM of the murine BCL1 tumor cells. This antiserum reacts exclusively with the IgM expressed on the tumor cells and detects a unique population of cells in the spleen and blood of the tumor-bearing mice. When these cells are stimulated in vitro with LPS, they secrete an IgM bearing the same idiotype as the cell surface Ig. These results are discussed in terms of a model for the immunotherapy of a chronic lymphocytic leukemia-like syndrome in mice.

View details for Web of Science ID A1979GU71100004

View details for PubMedID 109513